TP53 and B-cell chronic lymphocytic leukemia: In order to investigate the potential impact of the identified mutations on the functionality of p53 pathway, B-CLL patient derived cell cultures were treated in vitro for 24 hours with 10 microM of Nutlin-3, as previously described [19], before assessing the transcriptional activation of canonical target genes.